Delirium in the ICU from witness to criminal Dr. Andrew Ferguson MEd FRCA FCARCSI DIBICM FCCP
“ The subject of delirium is generally looked upon by the practical physician as one of the most obscure in the chain of morbid phenomena he has to deal with; whilst the frequency of its occurrence under various conditions of the system renders the affection not a little familiar to his eye” Gallway MB (1838). Nature and treatment of delirium. Lond Med Gazette 1: 46–49.
Overview What is  delirium ? How is it categorised? Why does it matter? Why does it happen? How do we diagnose/monitor it? How do we prevent and treat it? What does it mean for our patients?
What is Delirium? An  acute   confusional state  with Fluctuating  mental status Disordered  attention Disorganised  thinking  OR altered  consciousness DSM IV definition : “a disturbance of consciousness with inattention accompanied by a change in cognition or perceptual disturbance that develops over a short period (hours to days) and fluctuates with time” Synonyms : ICU psychosis, septic encephalopathy, ICU syndrome, acute brain failure, acute confusional state
How is Delirium Categorised? Hyperactive Hypoactive Mixed 1.6% of cases,  “ ICU psychosis ”, agitation, restlessness, “picking”, emotional lability 54.1% % of cases 43.5% of cases,  “ encephalopathy ”, often unrecognised, withdrawal, flat affect, apathy, lethargy, decreased responsiveness, may be misdiagnosed as depression
Why does delirium matter? Increased  reintubation  risk (OR=3) Increased  ICU & hospital stay *   (up to 10 days extra) Each day in delirium increases risk of longer stay by 20% Increased mortality in ICU & out to 6 months** (OR=3) Each day spent in delirium increases risk of death by 10% Increased  ICU & hospital costs *** 10-24% risk of  long-term cognitive impairment Increased  dementia risk Reduced functional status  at 3 & 6 months * Ely et al, Intensive Care Med 2001; 27: 1892-1900 ** Ely et al, JAMA 2004; 291: 1753-62 *** Milbrandt et al, CCM 2004; 32: 955-62
 
Why does delirium happen? Higher cortical dysfunction  (on functional neuroimaging) Pre-frontal cortex, non-dominant posterior parietal regions, anterior thalamus, basal ganglia, temporal-occipital cortex Neurotransmitter dysfunction Reduced acetylcholine levels – blockade or deficiency Endogenous anticholinergic substances Opiates/hypoxia/inflammation Serotonin fluctuation Dopamine excess Glutamate excess (2 o  to IFN-  , LPS, hypoxia, hypoglycaemia) Predisposition (baseline vulnerability) Precipitants (clinical, iatrogenic, organisational risk factors)
Why does delirium happen? Serotonin Acetylcholine Dopamine Opioids & benzo’s 2 o  brain infection Decreased cerebral metabolism 1 o  intracranial disease Systemic disease Hypoxia Metabolic derangement Withdrawal syndromes Toxins
Risk factors for delirium Van Rompaey Intensive and Critical Care Nursing 2008;  24: 98—107
Age Severity Benzo’s Pun & Ely, Chest 2007; 132: 624–636 Pandharipande et al, Anesthesiology 2006; 104: 21-26
DELIRIUM(S) - causes D Drugs, dementia E Eyes & ears (poor vision and hearing) L Low O 2  states (CHF, COPD, ARDS, MI, PE) I Infection  R Retention (urine and stool) I Ictal states U Underhydration/undernutrition M Metabolic upset (S) Subdural, sleep deprivation
I WATCH DEATH I Infection W Withdrawal (alcohol, sedatives, barbiturates etc.) A Acute metabolic (acidosis, alkalosis, electrolytes) T Trauma (closed head injury, haematoma etc.) C CNS pathology (seizures, stroke, encephalitis) H Hypoxia D Deficiencies (thiamine, niacin, B12, folate) E Endocrinopathies (thyroid, glucose, adrenal) A Acute vascular (hypertensive crisis, arrhythmia) T Toxins/drugs H Heavy metals
Diagnosis & monitoring Level  of consciousness Content  of consciousness
Diagnosis & monitoring Intensive Care Delirium Screening Checklist (ICDSC) 8 items based on data from preceeding 24 hours Score  >  4 items = positive for delirium Sensitivity 99%, specificity 64%, inter-observer reliability 94% Simple Confusion Assessment Method for ICU (CAM-ICU) 4 features Altered or fluctuating mental status compared to baseline Inattention (Attention Screening Examination – ASE, visual or auditory recollection of letter or images) Disorganised thinking – 4 Y/N questions + hold up 2 fingers on each hand Altered consciousness – sedation scale e.g. RASS Delirium = 1 AND 2 plus 3 OR 4
 
 
ICDSC
CAM-ICU
Treating delirium Non-pharmacological  (most studied outside ICU) Up to 40% risk reduction achieved Repeated reorientation of patients Early mobilisation Visual and hearing aids (and wax removal!) Early catheter, line etc. removal Minimise restraints and sedatives
Treating delirium -  haloperidol Typical  antipsychotic 2-5 mg iv/po q6H (reduce in elderly) Adverse effects  – extrapyramidal, prolonged QTc, torsades (3.8%), neuroleptic malignant syndrome More effective than lorazepam ? mortality reduction in ventilated ICU patients Dopamine blockade + disinhibition of ACh Anti-inflammatory effects Girard & Ely, Handbook of Clinical Neurology 2008; 90: chapter 3
Treating delirium – atypical antipsychotics Olanzepine, quetiapine, risperidone Alter multiple neurotransmitters  including DA, NA, serotonin, ACh, histamine Suggestion of decreased extrapyramidal side-effects compared to haloperidol As effective as haloperidol Girard & Ely , Handbook of Clinical Neurology 2008; 90: chapter 3 Skrobik YK, Bergeron N, Dumont M et al . (2004). Olanzapine vs haloperidol: treating delirium in a critical care set- ting. Intensive Care Med 30: 444–449.107: 341–351. Han CS, Kim YK  (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45: 297–301  Breitbart W,  Marotta R, Platt M  et al. (1996). A double- blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153: 231–237.
Internet Resources www.icudelirium.org

Delirium in the ICU

  • 1.
    Delirium in theICU from witness to criminal Dr. Andrew Ferguson MEd FRCA FCARCSI DIBICM FCCP
  • 2.
    “ The subjectof delirium is generally looked upon by the practical physician as one of the most obscure in the chain of morbid phenomena he has to deal with; whilst the frequency of its occurrence under various conditions of the system renders the affection not a little familiar to his eye” Gallway MB (1838). Nature and treatment of delirium. Lond Med Gazette 1: 46–49.
  • 3.
    Overview What is delirium ? How is it categorised? Why does it matter? Why does it happen? How do we diagnose/monitor it? How do we prevent and treat it? What does it mean for our patients?
  • 4.
    What is Delirium?An acute confusional state with Fluctuating mental status Disordered attention Disorganised thinking OR altered consciousness DSM IV definition : “a disturbance of consciousness with inattention accompanied by a change in cognition or perceptual disturbance that develops over a short period (hours to days) and fluctuates with time” Synonyms : ICU psychosis, septic encephalopathy, ICU syndrome, acute brain failure, acute confusional state
  • 5.
    How is DeliriumCategorised? Hyperactive Hypoactive Mixed 1.6% of cases, “ ICU psychosis ”, agitation, restlessness, “picking”, emotional lability 54.1% % of cases 43.5% of cases, “ encephalopathy ”, often unrecognised, withdrawal, flat affect, apathy, lethargy, decreased responsiveness, may be misdiagnosed as depression
  • 6.
    Why does deliriummatter? Increased reintubation risk (OR=3) Increased ICU & hospital stay * (up to 10 days extra) Each day in delirium increases risk of longer stay by 20% Increased mortality in ICU & out to 6 months** (OR=3) Each day spent in delirium increases risk of death by 10% Increased ICU & hospital costs *** 10-24% risk of long-term cognitive impairment Increased dementia risk Reduced functional status at 3 & 6 months * Ely et al, Intensive Care Med 2001; 27: 1892-1900 ** Ely et al, JAMA 2004; 291: 1753-62 *** Milbrandt et al, CCM 2004; 32: 955-62
  • 7.
  • 8.
    Why does deliriumhappen? Higher cortical dysfunction (on functional neuroimaging) Pre-frontal cortex, non-dominant posterior parietal regions, anterior thalamus, basal ganglia, temporal-occipital cortex Neurotransmitter dysfunction Reduced acetylcholine levels – blockade or deficiency Endogenous anticholinergic substances Opiates/hypoxia/inflammation Serotonin fluctuation Dopamine excess Glutamate excess (2 o to IFN-  , LPS, hypoxia, hypoglycaemia) Predisposition (baseline vulnerability) Precipitants (clinical, iatrogenic, organisational risk factors)
  • 9.
    Why does deliriumhappen? Serotonin Acetylcholine Dopamine Opioids & benzo’s 2 o brain infection Decreased cerebral metabolism 1 o intracranial disease Systemic disease Hypoxia Metabolic derangement Withdrawal syndromes Toxins
  • 10.
    Risk factors fordelirium Van Rompaey Intensive and Critical Care Nursing 2008; 24: 98—107
  • 11.
    Age Severity Benzo’sPun & Ely, Chest 2007; 132: 624–636 Pandharipande et al, Anesthesiology 2006; 104: 21-26
  • 12.
    DELIRIUM(S) - causesD Drugs, dementia E Eyes & ears (poor vision and hearing) L Low O 2 states (CHF, COPD, ARDS, MI, PE) I Infection R Retention (urine and stool) I Ictal states U Underhydration/undernutrition M Metabolic upset (S) Subdural, sleep deprivation
  • 13.
    I WATCH DEATHI Infection W Withdrawal (alcohol, sedatives, barbiturates etc.) A Acute metabolic (acidosis, alkalosis, electrolytes) T Trauma (closed head injury, haematoma etc.) C CNS pathology (seizures, stroke, encephalitis) H Hypoxia D Deficiencies (thiamine, niacin, B12, folate) E Endocrinopathies (thyroid, glucose, adrenal) A Acute vascular (hypertensive crisis, arrhythmia) T Toxins/drugs H Heavy metals
  • 14.
    Diagnosis & monitoringLevel of consciousness Content of consciousness
  • 15.
    Diagnosis & monitoringIntensive Care Delirium Screening Checklist (ICDSC) 8 items based on data from preceeding 24 hours Score > 4 items = positive for delirium Sensitivity 99%, specificity 64%, inter-observer reliability 94% Simple Confusion Assessment Method for ICU (CAM-ICU) 4 features Altered or fluctuating mental status compared to baseline Inattention (Attention Screening Examination – ASE, visual or auditory recollection of letter or images) Disorganised thinking – 4 Y/N questions + hold up 2 fingers on each hand Altered consciousness – sedation scale e.g. RASS Delirium = 1 AND 2 plus 3 OR 4
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
    Treating delirium Non-pharmacological (most studied outside ICU) Up to 40% risk reduction achieved Repeated reorientation of patients Early mobilisation Visual and hearing aids (and wax removal!) Early catheter, line etc. removal Minimise restraints and sedatives
  • 21.
    Treating delirium - haloperidol Typical antipsychotic 2-5 mg iv/po q6H (reduce in elderly) Adverse effects – extrapyramidal, prolonged QTc, torsades (3.8%), neuroleptic malignant syndrome More effective than lorazepam ? mortality reduction in ventilated ICU patients Dopamine blockade + disinhibition of ACh Anti-inflammatory effects Girard & Ely, Handbook of Clinical Neurology 2008; 90: chapter 3
  • 22.
    Treating delirium –atypical antipsychotics Olanzepine, quetiapine, risperidone Alter multiple neurotransmitters including DA, NA, serotonin, ACh, histamine Suggestion of decreased extrapyramidal side-effects compared to haloperidol As effective as haloperidol Girard & Ely , Handbook of Clinical Neurology 2008; 90: chapter 3 Skrobik YK, Bergeron N, Dumont M et al . (2004). Olanzapine vs haloperidol: treating delirium in a critical care set- ting. Intensive Care Med 30: 444–449.107: 341–351. Han CS, Kim YK (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45: 297–301 Breitbart W, Marotta R, Platt M et al. (1996). A double- blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153: 231–237.
  • 23.